Enveda Biosciences secured $55M to search the world's biodiversity for new medicines
Enveda Biosciences, a company building an advanced search engine for new drugs in the unexplored chemical space, announced a successful $55M Series B2 round to support its platform which helps researchers find multiple molecule candidates for targeted diseases and organs.